Experiment 1135041

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

CANNABINOL,DELTA-9-TETRAHYDRO:

Details

PropertyValue
Pharmacology
PHARMACOKINETIC STUDY OF
Administration routeGASTRIC INTUBATION
OrganismEmpty organism
CitationFRYTAK,S: MOERTEL,CG: RUBIN,J:. (1984). METABOLIC STUDIES OF DELTA-9-TETRAHYDROCANNABINOL IN CANCER PATIENTS.. 68(12)
Amount utilized
Compound isolated
Disease9 PATIENTS WITH GASTROINTESTINAL NEOPLASM WERE TREATED. MEAN HALF LIFE WAS ESTIMATED TO BE 1.5 HOURS. MULTIPLE DOSES DID NOT HAVE AN ADDITIVE EFFECT ON PLASMA LEVELS,NOR DID IT INCREASE ANTIEMETIC ACTIVITY.
Dose amount15.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE